Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.74 USD | +1.43% | +4.53% | +8.59% |
Apr. 18 | Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says | MT |
Apr. 18 | UK Regulator to Consider Undertakings for Theramex-Viatris Deal | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.59% | 13.74B | |
+25.97% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+19.37% | 332B | |
+3.34% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.10% | 145B |
- Stock Market
- Equities
- VTRS Stock
- News Viatris Inc.
- Viatris Launches of Ryzumvi Eye Drops to Reverse Dilation in US